Ophthalmic Device Industry Development Forum Held Concurrently with CCOS 2024

Globally, the ophthalmology sector has consistently drawn attention from clinical practitioners, policymakers, and investors."Golden Sector"During the 14th Five-Year Plan period, China also introduced several policies related to eye health to support and facilitate the development of the industry.

Given that most ophthalmic diseases are difficult to cure with medication, which typically only serves to slow disease progression, and considering the complexity of ocular anatomy that makes ophthalmic surgeries highly dependent on instruments, ophthalmic devices, compared to ophthalmic drugs, play a more significant role in clinical ophthalmology.plays a more critical role. Among these, the usage and demand for ophthalmic equipment, particularly mid-to-high-end ophthalmic devices with higher technological content, are continuously increasing.

Coinciding withThe 28th National Ophthalmology Academic Conference of the Chinese Medical Association (CCOS 2024)On the occasion of the event, to accelerate technological and commercial breakthroughs for domestic innovative ophthalmic enterprises and strengthen exchanges among ophthalmic device companies, He Eye Hospital Group Co., Ltd. jointly withShenyang He Eye Industry Group Co., Ltd., Guangzhou Ailuobo Medical Device Co., Ltd., and VCBeat, will jointly host the Ophthalmic Device Industry Development Forum on September 6, 2024, gathering industry leaders to build a platform for dialogue, exchange, and collaborative development in the ophthalmic device sector.

        Scan the QR code to register Scan the QR code to learn more about ophthalmology forum events